WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Michael August Rizzuto
Patent Agent
Patents and Innovations
San Diego
mrizzuto@wsgr.com

D858-350-2353

Download vCard
Open PDF

Michael Rizzuto is a patent agent in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s patents and innovations group. He focuses on patent prosecution primarily in diagnostics, medical technologies, and optical and electrical stimulation.

Prior to joining the firm, Michael worked as a patent examiner for the U.S. Patent and Trademark Office, reviewing and examining medical technology patent applications in art unit 3792. He has received training from the USPTO on the standards and practices of applying 101, 112, 102, and 103 rejections, and in particular 101 rejections applied to AI and machine learning systems for the use of diagnostics.

Michael has also spent time shadowing physicians and sitting in on surgical procedures at Tulane Lakeside Hospital, identifying market needs and working with the Tulane Medical School Simulation Center to develop training tools, systems, and methods for medical students.

Experience

Michael Rizzuto is a patent agent in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s patents and innovations group. He focuses on patent prosecution primarily in diagnostics, medical technologies, and optical and electrical stimulation.

Prior to joining the firm, Michael worked as a patent examiner for the U.S. Patent and Trademark Office, reviewing and examining medical technology patent applications in art unit 3792. He has received training from the USPTO on the standards and practices of applying 101, 112, 102, and 103 rejections, and in particular 101 rejections applied to AI and machine learning systems for the use of diagnostics.

Michael has also spent time shadowing physicians and sitting in on surgical procedures at Tulane Lakeside Hospital, identifying market needs and working with the Tulane Medical School Simulation Center to develop training tools, systems, and methods for medical students.

Education
  • M.S.E., Biomedical Engineering, Tulane University, 2020
  • B.S.E., Biomedical Engineering, Tulane University, 2019
Admissions
  • U.S. Patent and Trademark Office
Credentials
Education
  • M.S.E., Biomedical Engineering, Tulane University, 2020
  • B.S.E., Biomedical Engineering, Tulane University, 2019
Admissions
  • U.S. Patent and Trademark Office

Diagnostics and Medical Devices

  • Biomedical devices
  • Biomedical engineering
  • Biosensors
  • Diagnostics
  • Medical devices

Engineering and Technology

  • Biomechanics
  • Machine learning
  • Mechanical engineering
  • Microfluidics
Technical Fluency

Diagnostics and Medical Devices

  • Biomedical devices
  • Biomedical engineering
  • Biosensors
  • Diagnostics
  • Medical devices

Engineering and Technology

  • Biomechanics
  • Machine learning
  • Mechanical engineering
  • Microfluidics
Focus Areas
  • Biotech
  • Medical Devices
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises Amber Therapeutics on IP Matters Related to $100M Series A Financing, One of Europe's Largest for a MedTech Company
On June 10, 2024, Amber Therapeutics, a UK-based medical technology company, successfully closed a Series A financing, raising $100 million (£80 million) from leading healthcare and technology investors in the U.S. and U.K. The round, one of the largest Series A financings in Europe for a medical technology company, was led by New Enterprise Associates and included new investors F-Prime Capital, Lightstone Ventures, and Intuitive Ventures, along with existing investors Oxford Science Enterprises and 8VC. Wilson Sonsini Goodrich & Rosati advised Amber on IP matters and U.S. corporate, tax, and CFIUS issues in the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises on IP Matters in Amber Therapeutics’ Acquisition of Bioinduction
On September 5, 2023, Amber Therapeutics (Amber) announced that they acquired Bioinduction Limited (Bioinduction) and its Picostim DyNeuMo neuromodulation therapy platform. Wilson Sonsini advised Amber on intellectual property matters related to the acquisition.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.